TABLE 2—
Quality of Life and Symptoms of Distress Among Spanish-Speaking Latinas With Breast Cancer, by Treatment Group at Baseline, 3 Months, and 6 Months: Nuevo Amanecer Study; San Francisco Bay Area, CA; February 2011–May 2014
| Intervention, Mean (SD) | Control, Mean (SD) | Pa | |
| Breast cancer-specific quality of lifeb | |||
| Physical well-being (scale 0–24) | |||
| Baseline | 15.29 (5.78) | 16.76 (5.02) | .098 |
| 3 mo | 18.13 (4.81) | 18.01 (4.44) | .923 |
| 6 mo | 19.44 (4.26) | 18.44 (4.58) | .212 |
| Treatment × time interaction (0–3 mo) | .151 | ||
| Treatment × time interaction (0–6 mo) | .015 | ||
| Social/family well-being (scale 0–20) | |||
| Baseline | 13.67 (4.42) | 12.66 (4.25) | .154 |
| 3 mo | 13.57 (4.65) | 13.74 (4.24) | .732 |
| 6 mo | 13.72 (4.81) | 14.47 (3.81) | .293 |
| Treatment × time interaction (0–3 mo) | .071 | ||
| Treatment × time interaction (0–6 mo) | .025 | ||
| Emotional well-being (scale 0–20) | |||
| Baseline | 12.07 (4.91) | 12.86 (5.14) | .333 |
| 3 mo | 15.93 (3.52) | 14.73 (4.33) | .081 |
| 6 mo | 16.39 (3.30) | 14.89 (3.95) | .018 |
| Treatment × time interaction (0–3 mo) | .018 | ||
| Treatment × time interaction (0–6 mo) | .004 | ||
| Breast cancer concerns (scale 0–28) | |||
| Baseline | 16.52 (5.43) | 17.33 (5.08) | .344 |
| 3 mo | 19.91 (4.69) | 19.20 (4.69) | .396 |
| 6 mo | 21.31 (3.83) | 19.92 (5.22) | .083 |
| Treatment × time interaction (0–3 mo) | .08 | ||
| Treatment × time interaction (0–6 mo) | .013 | ||
| Enjoyment of life (scale 0–16) | |||
| Baseline | 8.92 (3.80) | 9.22 (3.43) | .61 |
| 3 mo | 9.70 (3.59) | 8.72 (3.28) | .103 |
| 6 mo | 9.79 (3.39) | 9.30 (3.06) | .41 |
| Treatment × time interaction (0–3 mo) | .048 | ||
| Treatment × time interaction (0–6 mo) | .267 | ||
| Overall quality of life (scale 0–108) | |||
| Baseline | 66.46 (16.92) | 68.83 (15.33) | .37 |
| 3 mo | 77.24 (15.13) | 74.39 (15.34) | .37 |
| 6 mo | 80.64 (13.64) | 77.02 (15.62) | .174 |
| Treatment × time interaction (0–3 mo) | .061 | ||
| Treatment × time interaction (0–6 mo) | .03 | ||
| General symptoms of distressc | |||
| Anxiety (scale 0–4) | |||
| Baseline | 0.93 (0.84) | 1.01 (0.88) | .577 |
| 3 mo | 0.48 (0.66) | 0.60 (0.73) | .32 |
| 6 mo | 0.39 (0.53) | 0.58 (0.76) | .09 |
| Treatment × time interaction (0–3 mo) | .808 | ||
| Treatment × time interaction (0–6 mo) | .465 | ||
| Depression (scale 0–4) | |||
| Baseline | 0.93 (0.84) | 0.75 (0.76) | .164 |
| 3 mo | 0.46 (0.59) | 0.52 (0.63) | .531 |
| 6 mo | 0.38 (0.48) | 0.46 (0.62) | .355 |
| Treatment × time interaction (0–3 mo) | .06 | ||
| Treatment × time interaction (0–6 mo) | .045 | ||
| Somatization (scale 0–4) | |||
| Baseline | 0.93 (0.78) | 0.75 (0.59) | .104 |
| 3 mo | 0.67 (0.65) | 0.74 (0.63) | .558 |
| 6 mo | 0.52 (0.51) | 0.66 (0.60) | .162 |
| Treatment × time interaction (0–3 mo) | .038 | ||
| Treatment × time interaction (0–6 mo) | .005 | ||
| Breast cancer-specific distressd | |||
| Intrusive thoughts scale (scale 0–35) | |||
| Baseline | 7.96 (8.46) | 8.65 (8.91) | .625 |
| 3 mo | 5.46 (7.52) | 7.04 (8.00) | .232 |
| 6 mo | 3.87 (5.79) | 6.27 (8.42) | .046 |
| Treatment × time interaction (0–3 mo) | .589 | ||
| Treatment × time interaction (0–6 mo) | .226 | ||
a
Group means were compared at each assessment. Treatment × time interaction from baseline to 3-month assessment is shortly after completing the intervention; treatment × time interaction from baseline to 6-month assessment is 3 months after intervention.
b
Functional Assessment of Cancer Therapy–Breast scores, modified; higher scores indicate better quality of life.
c
Brief Symptom Inventory; higher scores indicate more distress.
d
Intrusive Thoughts Scale; higher score indicates more distress.